US Cancer Vaccine Market Explored in New RNCOS E-Services Pvt. Ltd. Report Published at MarketPublishers.com

Share Article

New market research report “US Cancer Vaccine Market Analysis” elaborated by RNCOS E-Services has been recently published by Market Publishers Ltd. According to the report the US companies are set to maintain their position on the cancer vaccines market in the coming years due to highly successful results of their research activity.

Cancer treatment remains the burning issue even in the 21st century despite the discovery of new treatment techniques and medicines. Much attention is paid to the prevention of the disease. A large number of medical laboratories around the globe struggle to create the universal vaccine able to protect men from all cancer types.

Approximately 50 percent share in the cancer vaccines market belongs to the USA. Major companies engaged in this business are based or have offices in the country. They are set to maintain their position in the coming years due to highly successful results of their research activity.

New market research report “US Cancer Vaccine Market Analysis” elaborated by RNCOS E-Services Pvt. Ltd. provides a comprehensive guide to the US cancer vaccine market analysis. It offers a full coverage of the key market restraints and challenges, examines current market size and its major participants. Cancer statistics by demographics, valuable insight on key products available, the pipeline cancer vaccines, vaccine approval process and future outlook can be found in the study.

The companies covered in the research: Merck & Co., GSK, Dendreon, Bavarian Nordic, Celldex Therapeutics, Kael-GemVax, Oxford BioMedica, Galena Biopharma.

Report Details:

Title: US Cancer Vaccine Market Analysis
Published: September, 2012
Pages: 135
Price: US$ 1,200.00
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/drugs_biotechnology/us-cancer-vaccine-market-analysis.html

Report Contents:

1. ANALYST VIEW

2. RESEARCH METHODOLOGY

3. CANCER STATISTICS BY DEMOGRAPHICS

3.1 Prevalence, Incidences and Mortality (2008-2016)
3.2 Leading States by Incidence
3.3 Leading Cancers by Incidence
3.3.1 Male Cancer Incidences
3.3.2 Female Cancer Incidences
3.3.3 Age-Group

4. CANCER VACCINES MARKET OUTLOOK

4.1 Market Analysis and Segmentation
4.2 Key Product Analysis
4.2.1 Provenge
    4.2.1.1 Market Analysis
    4.2.1.2 Restraints
4.2.2 HPV Vaccine
    4.2.2.1 Gardasil
     4.2.2.1.1 Market Analysis
     4.2.2.1.2 Restraints
    4.2.2.2 Cervarix
     4.2.2.2.1 Market Analysis
     4.2.2.2.2 Restraints
4.2.3 HBV Vaccines
    4.2.3.1 Market Analysis
    4.2.3.2 Market Restraints
     4.2.3.2.1 Engerix-B and Twinrix
     4.2.3.2.2 Recombivax HB and Comvax
     4.2.3.2.3 Pediarix

5. POTENTIAL CANCER VACCINE CANDIDATES: AN OPPORTUNITY ASSESSMENT

5.1 Prophylactic Vaccine
5.2 Therapeutic Vaccine
5.2.1 Prostate Cancer
5.2.2 Breast Cancer

More new market research reports by the publisher can be found at RNCOS E-Services Pvt Ltd page.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tanya Rezler
Visit website